Return to homepagePandemic Pact

Immunovirological determinants of breakthrough COVID-19 disease in vaccinated or previously infected individuals

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:5 publications

Grant number: 202104PJT

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2026

  • Known Financial Commitments (USD)

    $755,437.5

  • Funder

    Canadian Institutes of Health Research (CIHR)

  • Research Location

    Canada

  • Lead Research Institution

    Centre hospitalier de l'Université de Montréal (CHUM)

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

5 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Weight Loss-Associated Remodeling of Adipose Tissue Immunometabolism.

Bouncing Beyond Adversity in Oncology: An Exploratory Study of the Association Between Professional Team Resilience at Work and Work-Related Sense of Coherence.

Resilience at Work among Healthcare Professionals in Oncology during and beyond the Pandemic: Report from A Deliberative Multi-Stakeholder Reflexive Symposium.

Building resilience in oncology teams: Protocol for a realist evaluation of multiple cases.

AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis.